Wall Street Journal @WSJ reporter covering pharma. Past: @DowJones Newswires, @LansReporter, Montgomeryville Spirit. 215-881-7127, peter.loftus@wsj.com

Thunderstorm Scatters Anti-Clinton Protesters, Who Vow to Fight On

blogs.wsj.com — A heavy thunderstorm scattered thousands of protesters away from the Democratic National Convention in Philadelphia Monday evening. But the rain didn't dampen their support for alternatives to presidential nominee Hillary Clinton. Many protesters-there to support Sen.

Philly Extends Last Call for Democratic Convention

blogs.wsj.com — PHILADELPHIA-If there are bleary-eyed delegates at next week's Democratic National Convention, consider this: last call will be later than usual in the host city. Pennsylvania Gov. Tom Wolf signed legislation last week to temporarily allow Philadelphia bars and restaurants hosting DNC-related events to serve alcohol past 2 a.m., the decades-old cutoff under state law.

Jury Acquits Former Johnson & Johnson Unit Execs of Felony Fraud

wsj.com — A federal jury in Boston on Wednesday found two former senior officers at a Johnson & Johnson division guilty of illegally marketing a medical device, but acquitted them of more serious charges including fraud, according to prosecutors and defense lawyers.

Merck & Co. Cutting Drug Research Jobs at 3 East-Coast Sites in Latest Shake-Up

wsj.com — Merck & Co. said it plans to lay off research-and-development workers at three East Coast sites in a shake-up of its early-stage drug-hunting efforts that also includes a new focus on the health effects of micro-organisms that populate the human body.

Merck Stops Development of Diabetes-Cholesterol Pill

wsj.com — Merck & Co. halted development of a pill combining its diabetes drug Januvia with a generic version of the widely used cholesterol fighter Lipitor, citing unspecified business reasons. The Whitehouse Station, N.J., company discontinued development of MK-0431E, which Merck had previously planned to submit for regulatory approval in 2014....

Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests

wsj.com — It doesn't take much to get a doctor to prescribe a brand-name medication, a new study suggests. The study found that U.S. doctors who received a single free meal from a drug company were more likely to prescribe the drug the company was promoting than doctors who received no such meals.

Former Warner Chilcott Executive Acquitted of Kickbacks Charge

wsj.com — News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. W. Carl Reichel, former president of pharmaceutical unit, was accused to payoffs to doctors A jury in federal court in Boston on Friday acquitted a former executive with Allergan PLC's Warner Chilcott unit of conspiring to pay kickbacks to doctors to prod them to prescribe the company's drugs, the U.S.

Judge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents

wsj.com — A federal judge has reversed a jury's verdict that Gilead Sciences Inc. should pay $200 million to Merck & Co. in a drug-patent dispute, after the judge concluded Merck engaged in misconduct in its efforts to obtain patents for hepatitis C drugs. U.S.

Judge throws out Merck’s $200 million verdict over Gilead

marketwatch.com — A federal judge has reversed a jury's verdict that Gilead Sciences Inc. should pay $200 million to Merck & Co. in a drug-patent dispute, after the judge concluded Merck engaged in misconduct in its efforts to obtain patents for hepatitis C drugs. U.S.

Combination Drug Therapies for Cancer Show Promise at Higher Potential Cost

nasdaq.com — By Peter Loftus CHICAGO -- Cancer researchers see promise in giving patients combinations of multiple drugs that are proving more effective than one or two. But the strategy poses a dilemma for health insurers and patients: even higher prices.
More Articles →
Jul 27, 2016

RT @chronicle: Get out your resumes, the Smithsonian is hiring a beer scholar:  http://chroni.cl/2aImkJn 

Jul 27, 2016

RT @TomBurtonWSJ: A second act for Dr. Sam Waksal, whose first act as ImClone CEO led to Erbitux, 5 years in prison. @WSJ @gzuckerman  http://goo.gl/j9WQaS 

Jul 27, 2016

Eli Lilly CEO John Lechleiter to retire, David Ricks to replace him  http://on.wsj.com/2av87n9  via @WSJ

Jul 26, 2016

RT @WSJ: From farm to pharma, former CEO Fred Hassan recalls first job as laborer  http://on.wsj.com/2a4C60L 

Jul 25, 2016

RT @matthewherper: Sanders: "The greed of the drug companies must end!" He says Medicare must be able to negotiate drug prices.

Jul 25, 2016

Some signs discarded by protesters outside the #DNCinPHL Monday night https://t.co/tKTQk5Xkr6


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.